Clinical trial
MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant…
NCT00275210 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00275210 |
|---|---|
| Title | MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer |
| Official title | Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colonic Neoplasms |
| Intervention type | Drug |
| Interventions | Oxaliplatin (SR96669) |
| Enrollment | 2,246 |
| Start date | Oct 1, 1998 |
| Primary completion | Apr 1, 2003 |
| Completion | Apr 1, 2003 |
| First posted | Jan 11, 2006 |
| Last update posted | Apr 20, 2009 |
| Countries | Australia, Austria, Belgium, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway and 7 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: